Colospan is a private, clinical stage medical device company developing a novel device aiming to alleviate the profound clinical and economic burden of anastomotic leaks and diverting colonic stomas following colorectal surgeries.

Colospan’s CG-100™ is an intraluminal bypass device that is inserted into the colon during the surgery and reduce the contact of fecal materials with the anastomotic site by that preventing the need for a stoma. Colospan improves patients’ quality of life and significantly reduce the healthcare cost.   CG-100™ is CE approved in Europe and currently being tested in a global pivotal clinical study.